Corona crisis has limited impact on infant participation in National Immunisation Programme Nearly all infants in the Netherlands are still participating in the National Immunisation Programme.
Initial results on how COVID-19 spreads within Dutch families The novel coronavirus is primarily spread amongst adults who are about the same age. Within families, the virus is mainly transmitted from adults to children.
Standards for three drugs in Dutch surface water RIVM proposes water quality standards for three drugs in surface water: carbamazepine (epilepsy), metoprolol (heart disease) and metformin (diabetes).
Safety of the nanomaterial SAS (silica) in food still uncertain Uncertainty still remains over the safety of the nanomaterial SAS in food. Food additive E551 consists of ‘synthetic amorphous silica’ (SAS) and is applied as an anti-caking agent.
Open and sustainable building for RIVM and MEB The Central Government Real Estate Agency has awarded the contract to build new premises for two knowledge institutes - RIVM and the MEB - to StruktonHurks.
No new MERS patients in the Netherlands Almost two months ago, two Dutch people were diagnosed with the MERS coronavirus.
Declaration PAN Europe regarding RIVM Statement of PAN Europe regarding the contents of her report ‘A Poisonous Injection’ June 26, 2014.
Average participation in the National Immunisation Programme in the Netherlands around 95% From the RIVM report 'Vaccination level of the National Immunisation Programme of the Netherlands' (report year 2014) the strong commitment of Community Health Services (GGD’s) and child welfare ce
Examine patients with acute Q fever again after a year If patients with acute Q fever are re-examined for antibodies one year after their infection, 98% of the patients with chronic Q fever can be detected.
Air quality improved, not everywhere below limit values In recent years there has been a decline in the average concentrations of fine particulates and nitrogen dioxide.